A New Paradigm for Aptamer Therapeutic AS1411 Action: Uptake by Macropinocytosis and Its Stimulation by a Nucleolin-dependent Mechanism

Overview

Journal Cancer Res

Specialty Oncology

Date 2010 Sep 24

PMID 20861190

Citations 168

Authors

E Merit Reyes-Reyes

Yun Teng

Paula J Bates

Affiliations

Soon will be listed here.

Abstract

AS1411 is a first-in-class anticancer agent, currently in phase II clinical trials. It is a quadruplex-forming oligodeoxynucleotide that binds to nucleolin as an aptamer, but its mechanism of action is not completely understood. Mechanistic insights could lead to clinically useful markers for AS1411 response and to novel targeted therapies. Previously, we proposed a model where cell surface nucleolin serves as the receptor for AS1411, leading to selective uptake in cancer cells. Here, we compare uptake of fluorophore-labeled AS1411 (FL-AS1411) in DU145 prostate cancer cells (sensitive to AS1411) and Hs27 nonmalignant skin fibroblasts (resistant to AS1411). Uptake of FL-AS1411 occurred by endocytosis in both cell types and was much more efficient than an inactive, nonquadruplex oligonucleotide. Unexpectedly, uptake of FL-AS1411 was lower in cancer cells compared with Hs27 cells. However, the mechanism of uptake was different, occurring by macropinocytosis in cancer cells, but by a nonmacropinocytic pathway in Hs27 cells. Additionally, treatment of various cancer cells with AS1411 caused hyperstimulation of macropinocytosis, provoking an increase in its own uptake, whereas no stimulation was observed for nonmalignant cells. Nucleolin was not required for initial FL-AS1411 uptake in DU145 cells but was necessary for induced macropinocytosis and FL-AS1411 uptake at later times. Our results are inconsistent with the previous mechanistic model but confirm that nucleolin plays a role in mediating AS1411 effects. The data suggest a new model for AS1411 action as well as a new role for nucleolin in stimulating macropinocytosis, a process with potential applications in drug delivery.

Citing Articles

Multifunctional molecular hybrid for targeted colorectal cancer cells: Integrating doxorubicin, AS1411 aptamer, and T9/U4 ASO.

Jiramitmongkon K, Rotkrua P, Khanchaitit P, Arunpanichlert J, Soontornworajit B PLoS One. 2025; 20(2):e0317559.

PMID: 39946362 PMC: 11825018. DOI: 10.1371/journal.pone.0317559.

Tanshinlactone triggers methuosis in breast cancer cells via NRF2 activation.

Lin W, Huang Z, Zhang X, Zheng D, Yang Y, Shi M Front Pharmacol. 2025; 15:1534217.

PMID: 39906392 PMC: 11790599. DOI: 10.3389/fphar.2024.1534217.

Methuosis, Alkaliptosis, and Oxeiptosis and Their Significance in Anticancer Therapy.

Bartoszewska E, Florek K, Zagorski K, Gachowska M, Wietrzyk A, Hutny A Cells. 2025; 13(24.

PMID: 39768186 PMC: 11674267. DOI: 10.3390/cells13242095.

Development of dual aptamers-functionalized c-MET PROTAC degraders for targeted therapy of osteosarcoma.

Fu X, Huang J, Chen X, Xie D, Chen H, Liang Z Theranostics. 2025; 15(1):103-121.

PMID: 39744222 PMC: 11667235. DOI: 10.7150/thno.99588.

Insights into the Molecular Structure, Stability, and Biological Significance of Non-Canonical DNA Forms, with a Focus on G-Quadruplexes and i-Motifs.

Obara P, Wolski P, Panczyk T Molecules. 2024; 29(19).

PMID: 39407611 PMC: 11477922. DOI: 10.3390/molecules29194683.

References

Chen X, Kube D, Cooper M, Davis P . Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA. Mol Ther. 2007; 16(2):333-42. DOI: 10.1038/sj.mt.6300365. View

Doherty G, McMahon H . Mechanisms of endocytosis. Annu Rev Biochem. 2009; 78:857-902. DOI: 10.1146/annurev.biochem.78.081307.110540. View

Li C, MacDonald J, Hryciw T, Meakin S . Nerve growth factor activation of the TrkA receptor induces cell death, by macropinocytosis, in medulloblastoma Daoy cells. J Neurochem. 2009; 112(4):882-99. DOI: 10.1111/j.1471-4159.2009.06507.x. View

Wittrup A, Sandgren S, Lilja J, Bratt C, Gustavsson N, Morgelin M . Identification of proteins released by mammalian cells that mediate DNA internalization through proteoglycan-dependent macropinocytosis. J Biol Chem. 2007; 282(38):27897-904. DOI: 10.1074/jbc.M701611200. View

Soundararajan S, Chen W, Spicer E, Courtenay-Luck N, Fernandes D . The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells. Cancer Res. 2008; 68(7):2358-65. DOI: 10.1158/0008-5472.CAN-07-5723. View

Hanakahi L, Dempsey L, Li M, Maizels N . Nucleolin is one component of the B cell-specific transcription factor and switch region binding protein, LR1. Proc Natl Acad Sci U S A. 1997; 94(8):3605-10. PMC: 20487. DOI: 10.1073/pnas.94.8.3605. View

Noguchi H, Bonner-Weir S, Wei F, Matsushita M, Matsumoto S . BETA2/NeuroD protein can be transduced into cells due to an arginine- and lysine-rich sequence. Diabetes. 2005; 54(10):2859-66. DOI: 10.2337/diabetes.54.10.2859. View

Mongelard F, Bouvet P . Nucleolin: a multiFACeTed protein. Trends Cell Biol. 2006; 17(2):80-6. DOI: 10.1016/j.tcb.2006.11.010. View

Alam M, Ming X, Dixit V, Fisher M, Chen X, Juliano R . The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking. Oligonucleotides. 2009; 20(2):103-9. PMC: 2883474. DOI: 10.1089/oli.2009.0211. View

10.

Bar-Sagi D, Feramisco J . Induction of membrane ruffling and fluid-phase pinocytosis in quiescent fibroblasts by ras proteins. Science. 1986; 233(4768):1061-8. DOI: 10.1126/science.3090687. View

11.

Xu X, Hamhouyia F, Thomas S, BURKE T, Girvan A, McGregor W . Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides. J Biol Chem. 2001; 276(46):43221-30. DOI: 10.1074/jbc.M104446200. View

12.

Hanakahi L, Bu Z, Maizels N . The C-terminal domain of nucleolin accelerates nucleic acid annealing. Biochemistry. 2000; 39(50):15493-9. DOI: 10.1021/bi001683y. View

13.

Magzoub M, Sandgren S, Lundberg P, Oglecka K, Lilja J, Wittrup A . N-terminal peptides from unprocessed prion proteins enter cells by macropinocytosis. Biochem Biophys Res Commun. 2006; 348(2):379-85. DOI: 10.1016/j.bbrc.2006.07.065. View

14.

Reyes-Reyes M, George M, Roberts J, Akiyama S . P-selectin activates integrin-mediated colon carcinoma cell adhesion to fibronectin. Exp Cell Res. 2006; 312(20):4056-69. PMC: 1853301. DOI: 10.1016/j.yexcr.2006.09.008. View

15.

Fumoto S, Nishi J, Ishii H, Wang X, Miyamoto H, Yoshikawa N . Rac-mediated macropinocytosis is a critical route for naked plasmid DNA transfer in mice. Mol Pharm. 2009; 6(4):1170-9. DOI: 10.1021/mp900042p. View

16.

Greenwood K, Daly N, Brown D, Stow J, Craik D . The cyclic cystine knot miniprotein MCoTI-II is internalized into cells by macropinocytosis. Int J Biochem Cell Biol. 2007; 39(12):2252-64. DOI: 10.1016/j.biocel.2007.06.016. View

17.

Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T . Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell. 2006; 10(6):839-50. DOI: 10.1016/j.devcel.2006.04.002. View

18.

Soundararajan S, Wang L, Sridharan V, Chen W, Courtenay-Luck N, Jones D . Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells. Mol Pharmacol. 2009; 76(5):984-91. PMC: 2774992. DOI: 10.1124/mol.109.055947. View

19.

Chi S, Kitanaka C, Noguchi K, Mochizuki T, Nagashima Y, Shirouzu M . Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells. Oncogene. 1999; 18(13):2281-90. DOI: 10.1038/sj.onc.1202538. View

20.

Mercer J, Helenius A . Virus entry by macropinocytosis. Nat Cell Biol. 2009; 11(5):510-20. DOI: 10.1038/ncb0509-510. View